Leading investigators offer 鈥榟ighly scientific, but patient-focused鈥� talks on women鈥檚 cancers at symposium
大象传媒 Lineberger鈥檚 46th聽annual Scientific Symposium on April 24-25 brought together more than 350 people in person and virtually to hear talks on the latest research on women鈥檚 cancers.
The day-and-a-half meeting was chaired by聽,听, and聽, and featured 15 presentations on women鈥檚 cancers, with a focus on breast, endometrial and ovarian cancers.
鈥淭his is the first symposium that was designed around a cancer type itself, rather than biologic and preclinical processes,鈥� Carey said, adding that she, Bae-Jump and Perou were intentional in this approach to bring together research insights from the lab, the clinic and the community. 鈥淭his made for a highly scientific, but patient-focused symposium.鈥�
Perou said this approach made it possible to cover a broad range of disciplines and topics that were all relevant to women鈥檚 health.
鈥淭hese topics ranged from molecular findings, to new possible biomarkers of treatment response, to new prevention strategies, to new clinical trials with exciting novel drugs,鈥� Perou said. 鈥淲e all got exposed to a huge diversity of topics that made us all think deeply about what we heard, and which will certainly influence our future research.鈥�
The symposium featured talks by presenters from outside 大象传媒: Diego Castrillon, MD, PhD, University of Texas 鈥� Southwestern Medical Center; Jose Conejo-Garcia, MD, PhD, Moffitt Cancer Center; Melissa Davis, PhD, Weill-Cornell School of Medicine; David Huntsman, MD, University of British Columbia; Sandra McAllister, PhD, Brigham & Women鈥檚 Hospital; Daniela Matei, MD, Northwestern School of Medicine; Nicholas Navin, PhD, University of Texas MD Anderson Cancer Center; Olufunmilayo I. Olopade, MD, FACP, University of Chicago; and Jeffrey Rosen, PhD, Baylor College of Medicine.
There were also talks by 大象传媒 Lineberger members:聽,听, and聽, as well as Bae-Jump, Carey and Perou.
For the second year, the symposium used a hybrid in-person/online format, which has expanded the meeting鈥檚 reach to include participants from North Carolina and across the United States. There were also participants from more than a dozen academic, medical and governmental institutions outside North Carolina, including Michigan State University, University of Notre Dame, University of Chicago, University of Pennsylvania, University of Pittsburgh, National Institutes of Health, Dana-Farber Cancer Institute, and MD Anderson.
This article originally appeared in .